GLP-1 Medications for Weight Loss and Lymphedema: Benefits, Risks & Latest Research
New weight loss medications are completely changing how doctors treat metabolic health. Brands like Ozempic, Wegovy, and Mounjaro help…
-
-
GLP-1 Therapy Linked to Sensory Disturbances in Type 2 Diabetes
Long-term use of glucagon-like peptide 1 receptor agonists is linked to a higher risk of disturbances in smell and…
-
GLP-1 Medications and Eating Disorders: Risks, Benefits, and What We Know
New weight loss drugs have completely changed how doctors treat obesity and type 2 diabetes. These famous medications, including…
-
Investigational DNA Platform Shows Extended Metabolic Benefits in Preclinical Diabetes Models
Researchers developed a new DNA-based delivery method that leads to sustained weight loss and improved glucose control in preclinical…
-
GLP-1 Receptor Agonists and Menstrual Cycle Changes: Clinical Considerations
Clinicians are seeing more patients ask about menstrual changes when treated with glucagon-like peptide-1 receptor agonists. Medications like semaglutide…
-
GLP-1 and Diet: What Foods Support Patient Nutritional Needs
Glucagon-like peptide-1 receptor agonists are now being used not just for diabetes management but also for treating obesity. These…
-
Common GLP-1 Medication Errors: What Patients and Healthcare Providers Need to Know
GLP-1 medications have completely changed how we treat type 2 diabetes and weight loss. Brands like Ozempic, Wegovy, and…
-
GLP-1 Medications Linked to Misuse in Eating Disorders
A new study in JAMA Psychiatry highlights a concerning trend with GLP-1 receptor agonists. Researchers found that 32 percent…
-
Oura and LillyDirect Partner to Enhance Support for GLP-1 Therapy Users
Oura and LillyDirect recently announced a strategic collaboration. This partnership supports patients utilizing GLP-1 therapies. Furthermore, LillyDirect customers receive…
-
Beyond Weight Loss How These Medications Benefit Heart Health
Cardiovascular disease and obesity represent two of the most consequential health challenges. Emerging evidence demonstrates that several receptor agonists…
